OPKO Health, Inc. Peo Actually Paid Comp Amt
OPKO Health, Inc. (OPK) reported Peo Actually Paid Comp Amt of $1.34 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-30.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:PeoActuallyPaidCompAmt · last filed 2026-04-30
| Period end | Peo Actually Paid Comp Amt 12 month |
|---|---|
| 2025-12-31 | $1.34M DEF 14A · filed 2026-04-30 |
| 2024-12-31 | $2.02M DEF 14A · filed 2026-04-30 |
| 2023-12-31 | $2.17M DEF 14A · filed 2026-04-30 |
| 2022-12-31 | -$1.25M DEF 14A · filed 2026-04-30 |
| 2021-12-31 | $2.40M DEF 14A · filed 2026-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |